Atlas Trials

Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction

Clinical trial NCT04731155 · RECRUITING

Trial details

NCT number
NCT04731155
Sponsor
Shanghai Tong Ren Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Early PCSK9 Inhibitor on Ventricular Remodling
Start date
2021-04-12
Primary completion
2025-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.